title: The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
abstract: Whole-body scintigraphy with 131I-meta-iodo-benzylguanidine 131I-MIBG) was performed in 41 patients with neuroblastoma. In patients with clinical remission no pathological concentration of 131I-MIBG was found. In 30 patients with residual, recurrent or metastatic disease neuroblastoma was correctly localized by 131I-MIBG scintigraphy. It is concluded that 131I-MIBG whole-body scintigraphy is useful in the diagnosis and follow-up of neuroblastoma.
authors.affiliation: Institute of Nuclear Medicine, University Clinical Centre, Belgrade.
authors.forename: I
authors.initials: I
authors.lastname: Zagar
authors.forename: S
authors.initials: S
authors.lastname: Mitrović
authors.forename: G
authors.initials: G
authors.lastname: Adanja
authors.forename: L
authors.initials: L
authors.lastname: Maksimović
authors.forename: P
authors.initials: P
authors.lastname: Ivanovski
authors.forename: R
authors.initials: R
authors.lastname: Han
authors.forename: K
authors.initials: K
authors.lastname: Kovacić
mesh_terms: D019797:3-Iodobenzylguanidine; D002648:Child; D002675:Child, Preschool; D003287:Contrast Media; D005260:Female; D006801:Humans; D007223:Infant; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D008297:Male; D009447:Neuroblastoma / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging
chemical_list: D003287:Contrast Media; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine